Evidence Paper Review

 Quick Explanation Copied

 Long Explanation

Core finding: Fiekers (1981) used two-microelectrode voltage clamp on garter snake (Thamnophis) costocutaneous twitch fibres to show that polymyxin B, already known as the most potent neuromuscular-blocking antibiotic, acts postjunctionally by directly blocking acetylcholine receptor channels Polymyxin B end-plate channel study.

Key quantitative evidence

• MEPC effects: Concentrations >10^-6 M reduced peak MEPC amplitude and accelerated decay, which remained a clean single exponential (linear semilog plots) — no shift in reversal potential (E_r −3.2±1.1 vs −4.8±0.9 mV), excluding altered ion selectivity.
• Channel kinetics from noise analysis: At −130 mV, corner frequency rose from 49 Hz (τ_N 3.3 ms) in control to 137 Hz (τ_N 1.1–1.2 ms) in 10^-6 M polymyxin B; averaged MEPC τ matched (3.5 → 1.2 ms) Noise-analysis kinetics of polymyxin B.
• Conductance: Single-channel conductance γ fell from 24.8±2.1 to 10.4±2.9 pS at −80 mV (n=6 fibres) — a ~58% reduction (paired design, each fibre its own control).
• Voltage dependence: Control τ_MEPC voltage coefficient A = 0.0146±0.003 mV^-1 (n=8); polymyxin B abolished or reversed it (−0.0055±0.002 at 10^-6 M; +0.0016±0.0005 at 2×10^-5 M), consistent with open-channel blockade by a charged molecule.

Critical appraisal

Strengths: Paired within-fibre design, convergence of two independent methods (MEPC decay vs ACh noise spectral analysis), and mechanistic coherence with the known clinical difficulty of reversing polymyxin B block with calcium or anticholinesterases. The mechanism parallels the author's earlier clindamycin and neomycin work and resembles local anaesthetic-type channel block (e.g., QX314, atropine).

Limitations and blind spots: (1) Small sample sizes — γ estimate from 6 fibres, voltage-coefficient from 4–8 end-plates; no statistical tests or dose-response EC50 reported in the excerpt. (2) Species extrapolation — snake end-plate kinetics differ from mammalian; the paper itself notes the snake preparation is electrophysiologically convenient but human applicability is inferred. Notably, later work from the same model showed snake slow-fibre end-plates harbor two distinct AChR channel types (S- vs T-type), which could heterogeneously modulate polymyxin B sensitivity, a channel population nuance unexplored here Snake slow-fibre dual AChR channel types. (3) Temperature (20–20.5°C) below mammalian physiology; channel kinetics are temperature-sensitive. (4) Presynaptic actions not excluded — the study addressed postjunctional channels only; prior literature cited suggests both pre- and postjunctional contributions, so channel blockade may be a major but not sole mechanism. (5) Open-channel vs closed-state block not kinetically distinguished — reduced γ could reflect brief flickery blocked events distorting averaged spectra; single-channel recording (later possible) would resolve this.

Confidence: The channel-blockade conclusion is well supported for this preparation (strong, convergent evidence); its quantitative generalization to clinical mammalian neuromuscular block is moderate. Evidence that would change the conclusion: demonstration that polymyxin B reduces ACh release presynaptically at concentrations below those affecting γ, or single-channel data showing normal γ with reduced open probability.

Compare Antibiotic Channel Blockade Mechanisms Graph Dose-Response Data

 BGPT Paper Review

Study Novelty

First direct voltage-clamp/noise evidence that polymyxin B blocks ACh receptor channels, but conceptually follows prior antibiotic (clindamycin, neomycin) and local anesthetic channel-block work; mechanism extension rather than new paradigm.

Scientific Quality

Rigorous paired voltage-clamp design with convergent methods (MEPC decay + noise spectra), but small n (4–8 fibres per measurement), no statistical testing reported, no dose-response modeling, and open vs closed channel block not distinguished.

Study Generality

Study Usefulness

Explains clinical difficulty reversing polymyxin B block (noncompetitive channel block unresponsive to calcium/anticholinesterases), informing anesthetic and ICU drug-interaction awareness.

Study Reproducibility

Methods (species, solutions, TTX, temperatures, analysis model of Anderson & Stevens) are clearly described and the technique standard, but no raw data or exact fibre counts per condition in full detail.

Explanatory Depth

Provides mechanistic depth at the single-channel level (γ, τ, voltage dependence) but does not kinetically model binding state (open vs closed block) or molecular interactions with the channel pore.